Palopegteriparatide
Records for this ingredient, by country (identity only).
ATC H05AA05 · 6 markets · 17 records
AU 4 records · 1 shown of 1
- 0.3 mg/mL per mL / per unit basis not statedinjectionYORVIPATH palopegteriparatide 168 micrograms / 0.56 mL solution for injection in multidose pre-filled penYORVIPATH palopegteriparatide 294 micrograms / 0.98 mL solution for injection in multidose pre-filled pen、YORVIPATH palopegteriparatide 420 micrograms / 1.4 mL solution for injection in multidose pre-filled pen
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 3 records · 3 shown of 3
GB 3 records · 3 shown of 3
- 1.4 mL per mL / per unit basis not statedinjectionYorvipath 420micrograms/1.4ml solution for injection pre-filled pens
- 0.98 mL per mL / per unit basis not statedinjectionYorvipath 294micrograms/0.98ml solution for injection pre-filled pens
- 0.56 mL per mL / per unit basis not statedinjectionYorvipath 168micrograms/0.56ml solution for injection pre-filled pens
CA 3 records · 3 shown of 3
FR 3 records · 3 shown of 3
- 0.42 mg/1.4 mLinjectionYORVIPATH 420 microgrammes/1,4 mL, solution injectable en stylo prérempli
- 0.294 mg/0.98 mLinjectionYORVIPATH 294 microgrammes/0,98 mL solution injectable en stylo prérempli
- 0.168 mg/0.56 mLinjectionYORVIPATH 168 microgrammes/0,56 mL, solution injectable en stylo prérempli
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.